ConductScience.org, home

Paper2938014

Induction of tolerance by monoclonal antibody therapy.

Benjamin RJ and 1 other. Nature, 1986. Cited by 322 papers, by iCite.

Cite this record

ConductScience Library. Induction of tolerance by monoclonal antibody therapy. Papers, record 2938014. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2938014

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Induction of tolerance by monoclonal antibody therapy.
PubMed
Journal
Nature
PubMed
Year
1986
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
322
iCite
Relative citation ratio, by iCite
7.11
iCite
Revised in PubMed
2021-12-03
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Benjamin RJR J
2Waldmann HH

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antibodies, MonoclonalMajor topic
Antigens, SurfaceMajor topic
Immunosuppression TherapyMajor topic
T-Lymphocytes, Helper-InducerMajor topic
Animals
Antibodies, Anti-Idiotypic
Antigens, Differentiation, T-Lymphocyte
Mice

Source PubMed

Download CSV of topics

Cited by59

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 322 citations.

PMIDTitleJournalYearIn PapersSource
38843866Unlocking Transplant Tolerance with Biomaterials.Adv Healthc Mater2025https://conductscience.org/library/papers/38843866PubMed
35774800A Recombinant MVA-Based RSV Vaccine Induces T-Cell and Antibody Responses That Cooperate in the Protection Against RSV Infection.Front Immunol2022https://conductscience.org/library/papers/35774800PubMed
35529847Transplant Tolerance, Not Only Clonal Deletion.Front Immunol2022https://conductscience.org/library/papers/35529847PubMed
32397343The Role of TNFR2 and DR3 in the In Vivo Expansion of Tregs in T Cell Depleting Transplantation Regimens.Int J Mol Sci2020https://conductscience.org/library/papers/32397343PubMed
31713816Molecular Approaches for the Treatment of Pompe Disease.Mol Neurobiol2020https://conductscience.org/library/papers/31713816PubMed
29165614Long-term health in recipients of transplanted in vitro propagated spermatogonial stem cells.Hum Reprod2018https://conductscience.org/library/papers/29165614PubMed
26865713Transient CD4+ T Cell Depletion Results in Delayed Development of Functional Vaccine-Elicited Antibody Responses.J Virol2016https://conductscience.org/library/papers/26865713PubMed
26110047Apoptotic cell-linked immunoregulation: implications for promoting immune tolerance in transplantation.Cell Biosci2015https://conductscience.org/library/papers/26110047PubMed
25382056Enhanced efficacy from gene therapy in Pompe disease using coreceptor blockade.Hum Gene Ther2015https://conductscience.org/library/papers/25382056PubMed
24691478Harnessing FOXP3+ regulatory T cells for transplantation tolerance.J Clin Invest2014https://conductscience.org/library/papers/24691478PubMed
24151492Interleukin 35: a key mediator of suppression and the propagation of infectious tolerance.Front Immunol2013https://conductscience.org/library/papers/24151492PubMed
22988034Foxp3 expression is required for the induction of therapeutic tissue tolerance.J Immunol2012https://conductscience.org/library/papers/22988034PubMed
22719741Boosting regulatory T cell function by CD4 stimulation enters the clinic.Front Immunol2012https://conductscience.org/library/papers/22719741PubMed
22205213The battle against immunopathology: infectious tolerance mediated by regulatory T cells.Cell Mol Life Sci2012https://conductscience.org/library/papers/22205213PubMed
21716299Successful attenuation of humoral immunity to viral capsid and transgenic protein following AAV-mediated gene transfer with a non-depleting CD4 antibody and cyclosporine.Gene Ther2012https://conductscience.org/library/papers/21716299PubMed
21593400Functional regulatory T cells produced by inhibiting cyclic nucleotide phosphodiesterase type 3 prevent allograft rejection.Sci Transl Med2011https://conductscience.org/library/papers/21593400PubMed
20717099Tolerance: an overview and perspectives.Nat Rev Nephrol2010https://conductscience.org/library/papers/20717099PubMed
19943950Protective versus pathogenic anti-CD4 immunity: insights from the study of natural resistance to HIV infection.J Transl Med2009https://conductscience.org/library/papers/19943950PubMed
18777090Regulation and privilege in transplantation tolerance.J Clin Immunol2008https://conductscience.org/library/papers/18777090PubMed
18701498Modulation of protective T cell immunity by complement inhibitor expression on tumor cells.Cancer Res2008https://conductscience.org/library/papers/18701498PubMed

See all 59 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2938014

GET https://conductscience.org/api/papers/v1/2938014/cited_by?page=2